Sexual health and contraception in the menopause journey

Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101822. doi: 10.1016/j.beem.2023.101822. Epub 2023 Sep 19.

Abstract

Women may experience changes in sexuality across menopause, because at this step in life hormone deficiency interacts with several determinants in a bio-psycho-social perspective. Healthcare providers should inform women about menopause impact on sexuality and be proactive during consultation in disclosing sexual concerns that would require a targeted assessment. Sexual symptoms become more frequent as women age, but they do not always translate into sexual dysfunction diagnosis, for which distress is required. It is important to recognize conditions that may increase the risk of dysfunctional response to menopause challenges in order to promote sexual longevity through counselling and specific management. In this review, we report key elements for a comprehensive assessment of sexual health around menopause, with a focus on genitourinary syndrome of menopause (GSM) and hypoactive sexual desire disorder (HSDD), representing well identified clinical conditions affecting sexuality at midlife and beyond. We also address the issue of contraception across the menopausal transition, highlighting risks and benefits, and possible implications on sexual function.

Keywords: GSM; HSDD; contraception; female sexual dysfunctions; genitourinary syndrome of menopause; hypoactive sexual desire disorder; menopause; perimenopause; vulvovaginal atrophy.

Publication types

  • Review

MeSH terms

  • Contraception*
  • Female
  • Humans
  • Menopause / physiology
  • Sexual Dysfunction, Physiological* / etiology
  • Sexual Dysfunctions, Psychological* / diagnosis
  • Sexual Dysfunctions, Psychological* / etiology
  • Sexual Health*